Phase I Trial of The Combination of Vismodegib and Sirolimus
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Sirolimus (Primary) ; Vismodegib (Primary)
- Indications Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- 21 Mar 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
- 29 Oct 2015 Status changed from active, no longer recruiting to suspended, according to ClinicalTrials.gov record.
- 12 Apr 2012 New source identified and integrated (Mayo Clinic).